ImmunoGen, Inc.

Ownership Transactions Reported by 20 Insiders

Industry
Pharmaceutical Preparations
Location
830 Winter St, Waltham, MA

There are no Buy or Sell transactions made by insiders since 4/22/2024

ImmunoGen, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Anna Berkenblit Svp & Chief Medical Officer $6.57M Jun 30, 2023
Susan ALTSCHULLER Svp And Cfo $2.57M May 20, 2022
Thomas Ryll SVP, Technical Operations $2.51M Jun 30, 2021
Kristen Harrington-Smith Svp & Chief Commercial Officer $2.21M Nov 15, 2022
Stacy Ann Coen Svp & Chief Business Officer $1.57M Feb 12, 2024
Mark J. Enyedy CHIEF EXECUTIVE OFFICER, Director $1.02M Feb 12, 2024
Renee Lentini Vp & Prin Acctg Officer $279K Feb 12, 2024
Stuart A. Arbuckle Director $102K Feb 12, 2024
Helen M. Thackray Director $102K Feb 12, 2024
Mark Alan Goldberg Director $0 Feb 12, 2024
Dean J. Mitchell Director $0 Feb 12, 2024
Daniel Char Svp & Chief Legal Officer $0 Feb 12, 2024
Tracey L. McCain Director $0 Feb 12, 2024
Michael Vasconcelles Evp R&D & Medical Affairs $0 Feb 12, 2024
Stephen Mccluski Director $0 Feb 12, 2024
Richard John Wallace Director $0 Feb 12, 2024
Theresa Wingrove Svp Of Regulatory Affairs $0 Feb 12, 2024
Isabel Kalofonos Svp & Chief Commercial Officer $0 Feb 12, 2024
Lauren White Svp, Cfo And Pfo $0 Feb 12, 2024
Kristine Peterson Director $0 Feb 12, 2024

Recent Insider Transactions by Companies or Individuals for ImmunoGen, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.